Literature DB >> 15225113

Platelet activation in myocardial ischemic syndromes.

Paul A Gurbel1, Kevin P Bliden, Kevin M Hayes, Udaya Tantry.   

Abstract

Platelets play a central role in the pathogenesis of atherosclerosis and thrombosis. Platelet adhesion and aggregate formation are critical events that occur in unstable coronary syndromes. Platelet activation precedes the formation of homotypic and heterotypic aggregates. In the last 10 years, researchers have described the presence of activated platelets in the systemic circulation in various cardiovascular disease states, particularly acute coronary syndromes. This review describes the evidence for platelet activation in acute myocardial ischemic syndromes, describes the pathophysiology responsible for its occurrence, and discusses how platelet activation and reactivity may affect the use of concomitant drug therapies and patient prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225113     DOI: 10.1586/14779072.2.4.535

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  15 in total

Review 1.  Pharmacology of antiplatelet agents.

Authors:  Kiran Kalra; Christopher J Franzese; Martin G Gesheff; Eli I Lev; Shachi Pandya; Kevin P Bliden; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

2.  The P2Y(12) receptor as a target of antithrombotic drugs.

Authors:  Stephen O'Connor; Gilles Montalescot; Jean-Philippe Collet
Journal:  Purinergic Signal       Date:  2011-06-28       Impact factor: 3.765

3.  Novel antiplatelet agents in cardiovascular medicine.

Authors:  Rahil Rafeedheen; Kevin P Bliden; Fang Liu; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

4.  Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.

Authors:  Charles V Pollack; Farideh Davoudi; Deborah B Diercks; Richard C Becker; Stefan K James; Soo Teik Lim; Phillip J Schulte; Jindrich Spinar; Philippe Gabriel Steg; Robert F Storey; Anders Himmelmann; Lars Wallentin; Christopher P Cannon
Journal:  Clin Cardiol       Date:  2017-06-09       Impact factor: 2.882

Review 5.  G-protein-coupled receptors signaling pathways in new antiplatelet drug development.

Authors:  Paul A Gurbel; Athan Kuliopulos; Udaya S Tantry
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-29       Impact factor: 8.311

Review 6.  Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4.

Authors:  Wei C Lau; Paul A Gurbel
Journal:  Pharm Res       Date:  2006-10-24       Impact factor: 4.200

Review 7.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

8.  Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004.

Authors:  Jeffrey S Berger; Luis H Eraso; Dawei Xie; Daohang Sha; Emile R Mohler
Journal:  Atherosclerosis       Date:  2010-09-18       Impact factor: 5.162

9.  Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment.

Authors:  Raisuke Iijima; Gjin Ndrepepa; Julinda Mehilli; Franz-Josef Neumann; Stefanie Schulz; Jurriën ten Berg; Olga Bruskina; Franz Dotzer; Josef Dirschinger; Peter B Berger; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

10.  Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study.

Authors:  Imo E Hoefer; Jan-Willem Sels; J Wouter Jukema; Sandrin Bergheanu; Erik Biessen; Elizabeth McClellan; Mat Daemen; Pieter Doevendans; Philip de Groot; Marieke Hillaert; Sebastiaan Horsman; Mustafa Ilhan; Johan Kuiper; Nico Pijls; Ken Redekop; Peter van der Spek; Andrew Stubbs; Eric van de Veer; Johannes Waltenberger; Anton-Jan van Zonneveld; Gerard Pasterkamp
Journal:  Clin Res Cardiol       Date:  2013-08-23       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.